[Chinese guidelines for the treatment and evaluation of IgG4-related disease (2026 edition)].
- DOI
- 10.3760/cma.j.cn112137-20260706-01696
- Published
- 2026 Oct 13
- Container
- Zhonghua yi xue za zhi
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3760/cma.j.cn112137-20260706-01696,
title = {[Chinese guidelines for the treatment and evaluation of IgG4-related disease (2026 edition)].},
author = {Chinese Rheumatology Association and IgG4-Related Disease Collaborative Group, Committee of Rheumatology and Immunology, Cross-Strait Medicine Exchange Association},
year = {2026},
journal = {Zhonghua yi xue za zhi},
doi = {10.3760/cma.j.cn112137-20260706-01696},
url = {https://doi.org/10.3760/cma.j.cn112137-20260706-01696}
}RIS
TY - JOUR TI - [Chinese guidelines for the treatment and evaluation of IgG4-related disease (2026 edition)]. AU - Chinese Rheumatology Association AU - IgG4-Related Disease Collaborative Group, Committee of Rheumatology and Immunology, Cross-Strait Medicine Exchange Association PY - 2026 JO - Zhonghua yi xue za zhi DO - 10.3760/cma.j.cn112137-20260706-01696 UR - https://doi.org/10.3760/cma.j.cn112137-20260706-01696 ER -
APA
Association, C. R., & Association, I. D. C. G. C. O. R. A. I. C. M. E. (2026). [Chinese guidelines for the treatment and evaluation of IgG4-related disease (2026 edition)].. Zhonghua yi xue za zhi. https://doi.org/10.3760/cma.j.cn112137-20260706-01696
Source records
- pubmed · retrieved 2026-11-10T19:08:48.377Z